Cargando…

Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation

Permanent neonatal diabetes mellitus refers to diabetes that occurs before the age of 6 months and persists through life. It is a rare disorder affecting one in 0.2-0.5 million live births. Mutations in the gene KCNJ11, encoding the subunit Kir6.2, and ABCC8, encoding SUR1 of the ATP-sensitive potas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sung Yeon, Kim, Gu-Hwan, Yoo, Han-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573445/ https://www.ncbi.nlm.nih.gov/pubmed/26388896 http://dx.doi.org/10.3345/kjp.2015.58.8.309

Ejemplares similares

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
por: Cho, Ja Hyang, et al.
Publicado: (2017)

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

Sulfonylurea Therapy in Two Korean Patients with Insulin-treated Neonatal Diabetes due to Heterozygous Mutations of the KCNJ11 Gene Encoding Kir6.2
por: Kim, Min Sun, et al.
Publicado: (2007)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation
por: Philla, Katherine Q., et al.
Publicado: (2013)

MON-121 Successful Transition from Insulin to Sulfonylurea for a 26 Year Old Female with Neonatal Diabetes Secondary to KCNJ11 Gene Mutation
por: Ali, Sulaiman, et al.
Publicado: (2019)

Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old female with neonatal diabetes secondary to KCNJ11 gene mutation
por: Hajji, Sulaiman, et al.
Publicado: (2021)

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
por: Bowman, Pamela, et al.
Publicado: (2018)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
por: Shah, Reshma P., et al.
Publicado: (2012)

Sulfonylurea Use During Entire Pregnancy in Diabetes Because of KCNJ11 Mutation: A Report of Two Cases
por: Gaal, Zsolt, et al.
Publicado: (2012)

Changing the Treatment of Permanent Neonatal Diabetes Mellitus from Insulin to Glibenclamide in a 4-Month-Old Infant with KCNJ11 Activating Mutation
por: Ilkhanipoor, Homa, et al.
Publicado: (2013)

Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene
por: Al-Mahdi, Maria, et al.
Publicado: (2010)

Case report: Neonatal diabetes mellitus caused by KCNJ11 mutation presenting with intracranial hemorrhage
por: Wu, Bo, et al.
Publicado: (2023)

Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11
por: Yoon, Jong Seo, et al.
Publicado: (2018)

A Novel KCNJ11 Mutation Associated with Transient Neonatal Diabetes
por: Gole, Evangelia, et al.
Publicado: (2018)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
por: Philla, Katherine Q., et al.
Publicado: (2014)

Permanent Neonatal Diabetes Mellitus: Same Mutation, Different Glycemic Control with Sulfonylurea Therapy on Long-Term Follow-up
por: Küçükemre Ay, Banu, et al.
Publicado: (2012)

Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K(ATP)-channel pathways
por: Bowman, Pamela, et al.
Publicado: (2019)

Permanent Neonatal Diabetes in a Patient with a KCNJ11/Q52R Mutation Accompanied by Intermittent Hypoglycemia and Liver Failure
por: Shaw, Natalie D., et al.
Publicado: (2009)

SUN-278 Neonatal Diabetes in an Infant with Heterozygous Mutation in KCNJ11 Gene
por: Kota, Archana, et al.
Publicado: (2019)

Psychiatric morbidity in children with KCNJ11 neonatal diabetes
por: Bowman, P., et al.
Publicado: (2016)

KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus
por: Haghvirdizadeh, Polin, et al.
Publicado: (2015)

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
por: Kapoor, R. R., et al.
Publicado: (2011)

Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
por: Mancioppi, Valentina, et al.
Publicado: (2023)

First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment
por: Ioacara, Sorin, et al.
Publicado: (2017)

Transient Neonatal Diabetes due to a Mutation in KCNJ11 in a Child with Klinefelter Syndrome
por: Dahl, Amanda R., et al.
Publicado: (2018)

Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea
por: Fu, Jun-Ling, et al.
Publicado: (2019)

A novel mutation KCNJ11 R136C caused KCNJ11-MODY
por: Chen, Yaning, et al.
Publicado: (2021)

A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus
por: Ünal, Sevim, et al.
Publicado: (2016)

Successful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy
por: Chen, Ting, et al.
Publicado: (2018)

Permanent neonatal diabetes mellitus
por: Al-Matary, Abdulrahman, et al.
Publicado: (2012)

Successful transition from insulin to sulphonylurea in a child with neonatal diabetes mellitus diagnosed beyond six months of age due to C42R mutation in the KCNJ11 gene
por: Poon, Sarah Wing-yiu, et al.
Publicado: (2022)

Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation
por: Iafusco, Dario, et al.
Publicado: (2021)

KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment
por: Song, Jingwen, et al.
Publicado: (2017)

Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring
por: Lee, Ming Yeh, et al.
Publicado: (2023)

Permanent neonatal diabetes mellitus in China
por: Huang, Ke, et al.
Publicado: (2014)

Permanent neonatal diabetes mellitus in China
por: Huang, Ke, et al.
Publicado: (2015)

Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk
por: Vedovato, Natascia, et al.
Publicado: (2016)

Independent case-control study in KCNJ11 gene polymorphism with Type 2 diabetes Mellitus
por: Alqadri, Nada
Publicado: (2022)

KCNJ11 and KCNQ1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes Mellitus
por: Majcher, Sandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fn23g3kck791cc8vam6kn1a4b5